Belgian equities closed the trading session higher on Wednesday, driven by advances in the Consumer Services, Industrials and Healthcare sectors. At the Brussels close the benchmark BEL 20 index registered a gain of 0.17%.
The session's strongest performers on the BEL 20 included Anheuser Busch Inbev SA NV (EBR:ABI), which climbed 2.26% - a rise of 1.60 points - to finish at 72.40. Argen-X (EBR:ARGX) added 2.16%, up 15.00 points to end at 709.20, and Melexis NV (EBR:MLXS) rose 0.74%, or 0.60 points, to 81.65 at the close.
On the downside, Umicore SA (EBR:UMI) was the weakest name in the index, easing 3.32% or 0.88 points to close at 25.62. Elia (EBR:ELI) declined 2.44%, losing 3.40 points to finish at 135.90, and Ageas (EBR:AGES) slipped 1.17% or 0.80 points to 67.75.
Market breadth on the Brussels Stock Exchange favoured advancers, with 55 stocks rising versus 40 falling, and 14 issues unchanged.
Notably, shares of Anheuser Busch Inbev SA NV rose to 5-year highs in the session, gaining 2.26% or 1.60 to reach 72.40.
Commodity markets saw notable weakness during the European session. Gold Futures for August delivery fell 1.45%, down 65.85 to $4,469.15 a troy ounce. In energy markets, crude oil for July delivery dropped 3.90%, or 3.66, to $90.23 a barrel, while the August Brent contract fell 3.18%, or 3.07, to trade at $93.60 a barrel.
Foreign exchange movements were subdued. EUR/USD was effectively unchanged, moving 0.02% to 1.16, and EUR/GBP was unchanged at 0.87 with a 0.17% reading reported. The US Dollar Index Futures was up 0.07% at 99.17.
The session presented a mixed picture: modest index gains led by a handful of names, broader commodity declines and limited movement in major currency pairs.